Cargando…
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845554/ https://www.ncbi.nlm.nih.gov/pubmed/33524477 http://dx.doi.org/10.1016/j.annonc.2021.01.069 |
_version_ | 1783644575179472896 |
---|---|
author | Montopoli, M. Zorzi, M. Cocetta, V. Prayer-Galetti, T. Guzzinati, S. Bovo, E. Rugge, M. Calcinotto, A. |
author_facet | Montopoli, M. Zorzi, M. Cocetta, V. Prayer-Galetti, T. Guzzinati, S. Bovo, E. Rugge, M. Calcinotto, A. |
author_sort | Montopoli, M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7845554 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78455542021-02-01 Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy Montopoli, M. Zorzi, M. Cocetta, V. Prayer-Galetti, T. Guzzinati, S. Bovo, E. Rugge, M. Calcinotto, A. Ann Oncol Letter to the Editor European Society for Medical Oncology. Published by Elsevier Ltd. 2021-05 2021-01-29 /pmc/articles/PMC7845554/ /pubmed/33524477 http://dx.doi.org/10.1016/j.annonc.2021.01.069 Text en © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Montopoli, M. Zorzi, M. Cocetta, V. Prayer-Galetti, T. Guzzinati, S. Bovo, E. Rugge, M. Calcinotto, A. Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy |
title | Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy |
title_full | Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy |
title_fullStr | Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy |
title_full_unstemmed | Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy |
title_short | Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy |
title_sort | clinical outcome of sars-cov-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845554/ https://www.ncbi.nlm.nih.gov/pubmed/33524477 http://dx.doi.org/10.1016/j.annonc.2021.01.069 |
work_keys_str_mv | AT montopolim clinicaloutcomeofsarscov2infectioninbreastandovariancancerpatientswhounderwentantiestrogenictherapy AT zorzim clinicaloutcomeofsarscov2infectioninbreastandovariancancerpatientswhounderwentantiestrogenictherapy AT cocettav clinicaloutcomeofsarscov2infectioninbreastandovariancancerpatientswhounderwentantiestrogenictherapy AT prayergalettit clinicaloutcomeofsarscov2infectioninbreastandovariancancerpatientswhounderwentantiestrogenictherapy AT guzzinatis clinicaloutcomeofsarscov2infectioninbreastandovariancancerpatientswhounderwentantiestrogenictherapy AT bovoe clinicaloutcomeofsarscov2infectioninbreastandovariancancerpatientswhounderwentantiestrogenictherapy AT ruggem clinicaloutcomeofsarscov2infectioninbreastandovariancancerpatientswhounderwentantiestrogenictherapy AT calcinottoa clinicaloutcomeofsarscov2infectioninbreastandovariancancerpatientswhounderwentantiestrogenictherapy |